Senior Leadership at the UT Southwestern Simmons Cancer Center is comprised of the Director, Deputy Director, three Associate Directors representing basic, clinical and population research and the Associate Director for Administration. These leaders are responsible for collaborations across the scientific programs of the Center, direction and strategic planning, oversight of shared resources, education, and development of community outreach and budgetary oversight. Over the past four years. Dr. James Willson has provided vision and strong leadership as Director of UT Southwestern Simmons Cancer Center. Dr. Joan Schiller was appointed Deputy Director in 2006 and has led the development of the Center's disease oriented teams and an enabling clinical research infrastructure that has been integrated with the Medical Center's affiliated hospitals. Dr. Michael White serves as Associate Director for Basic Research and in this role has been instrumental in the development of the Center's basic research programs and the engagement of UT Southwestern cancer researchers into the Cancer Center. Dr. David Euhus serves as Associate Director for Clinical Research and in this role he is responsible for developing and maintaining a robust clinical trials enterprise for the Cancer Center and in partnership with the Deputy Director has responsibility for the oversight of the clinical trials support resources and the protocol review and monitoring system. Dr. Celette Sugg Skinner, who joined the Simmons Cancer Center in 2007, serves as Associate Director for Population Science. In this role she is leading the development of a research program in population science and cancer control and building interactions between basic and clinical faculty across the cancer control spectrum. This leadership team functions as a cohesive group that together has catalyzed new transdisciplinary collaborations and coordination that are transforming the cancer research environment at UT Southwestern.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA142543-04
Application #
8519952
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$123,220
Indirect Cost
$27,467
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Wong, Mandy S; Wright, Woodring E; Shay, Jerry W (2014) Alternative splicing regulation of telomerase: a new paradigm? Trends Genet 30:430-8
Chau, Vincent; Lim, S Kyun; Mo, Wei et al. (2014) Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors. Cancer Res 74:586-97
Iscla, Irene; Wray, Robin; Wei, Shuguang et al. (2014) Streptomycin potency is dependent on MscL channel expression. Nat Commun 5:4891
Fu, Peng; Johnson, Melissa; Chen, Hong et al. (2014) Carpatamides A-C, cytotoxic arylamine derivatives from a marine-derived Streptomyces sp. J Nat Prod 77:1245-8
Park, Jason Y; Gunpat, Joshua; Liu, Li et al. (2014) Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions. Luminescence 29:553-8
Gerber, David E; Laccetti, Andrew L; Xuan, Lei et al. (2014) Impact of prior cancer on eligibility for lung cancer clinical trials. J Natl Cancer Inst 106:
Yang, Liu; Kwon, Junghee; Popov, Yury et al. (2014) Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146:1339-50.e1
Li, Biaoru; Ding, Lianghao; Yang, Chinrang et al. (2014) Characterization of transcription factor networks involved in umbilical cord blood CD34+ stem cells-derived erythropoiesis. PLoS One 9:e107133
Ludlow, Andrew T; Robin, Jerome D; Sayed, Mohammed et al. (2014) Quantitative telomerase enzyme activity determination using droplet digital PCR with single cell resolution. Nucleic Acids Res 42:e104
King, Kelly A; Gordon-Salant, Sandra; Pawlowski, Karen S et al. (2014) Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C. J Assoc Res Otolaryngol 15:529-41

Showing the most recent 10 out of 83 publications